Financial Performance - For the fiscal year ending March 31, 2025, the group's revenue was approximately HKD 403.15 million, a decrease of about HKD 91.11 million or 18.4% compared to HKD 494.26 million for the fiscal year ending March 31, 2024[3]. - The company reported a profit attributable to equity holders of approximately HKD 10.6 million for the fiscal year ending March 31, 2025, reversing from a loss of HKD 12.6 million for the fiscal year ending March 31, 2024[3]. - Basic earnings per share for the fiscal year ending March 31, 2025, was HKD 0.0265, compared to a basic loss per share of HKD 0.0315 for the previous year[3]. - The group reported a net loss of HKD 10,590,000 for the year, with no potential dilutive ordinary shares issued[24]. - The group reported revenue of HKD 403.2 million for the fiscal year 2025, a decrease of 18.4% compared to HKD 494.3 million in fiscal year 2024[29]. - The group incurred income tax expenses of HKD 12,427,000 in 2025, compared to HKD 836,000 in 2024[21]. - The company expects to report a profit attributable to shareholders of approximately HKD 10.6 million in FY2025, compared to a loss of HKD 12.6 million in FY2024[47]. Assets and Liabilities - Total non-current assets decreased to HKD 156.29 million in 2025 from HKD 196.88 million in 2024[5]. - Current assets increased to HKD 314.99 million in 2025 from HKD 282.56 million in 2024, with cash and cash equivalents rising to HKD 182.32 million from HKD 119.83 million[5]. - Total current liabilities decreased to HKD 263.85 million in 2025 from HKD 277.98 million in 2024[5]. - The company's total assets less current liabilities increased to HKD 207.43 million in 2025 from HKD 201.47 million in 2024[5]. - The company reported a net cash position of HKD 51.14 million in 2025, compared to HKD 4.59 million in 2024[5]. - Non-current assets total HKD 168,997,000 in 2025, an increase from HKD 128,839,000 in 2024[15]. - Total non-current liabilities amount to HKD 59,866,000 in 2025, down from HKD 64,703,000 in 2024, indicating a decrease of 7.1%[6]. Revenue Breakdown - Revenue from treatment services was approximately HKD 350.3 million, accounting for 86.9% of total revenue, a decrease of about HKD 24.2 million or 6.5% due to a relatively weak economic environment[37]. - Revenue from skincare products dropped significantly to HKD 52,804,000 in 2025 from HKD 119,641,000 in 2024, representing a decline of 55.9%[17]. - Revenue from Hong Kong for 2025 is expected to be HKD 400,318,000, down 11.2% from HKD 450,819,000 in 2024[15]. Operational Efficiency - The company is focusing on improving operational efficiency and exploring new market opportunities to drive future growth[4]. - Operating profit before interest, tax, and depreciation increased to HKD 58.6 million, up 84.9% from HKD 31.7 million in the previous fiscal year[29]. - Operating expenses were reduced by 24.5% year-on-year, significantly lowering the expense-to-revenue ratio[30]. - Employee costs decreased by approximately HKD 42.2 million or 23.0% to about HKD 141.6 million in fiscal year 2025, mainly due to the optimization of operational structure and systems[41]. - Property rental and related expenses are expected to decrease from approximately HKD 67.9 million in FY2024 to HKD 54.2 million in FY2025, a reduction of about HKD 13.7 million or 20.2% due to network optimization and better lease terms negotiations[42]. - Other expenses are expected to decrease from approximately HKD 159.6 million in FY2024 to HKD 100.1 million in FY2025, a reduction of about HKD 59.5 million or 37.3%[44]. Market and Strategic Focus - The company operates primarily in the medical beauty and lifestyle beauty services sector, focusing on Hong Kong and mainland China markets[13]. - The market for medical beauty and lifestyle beauty in Hong Kong is expected to continue growing, driven by increasing consumer demand and technological advancements[28]. - The company is focusing on innovation in medical beauty services and expanding its diverse customer base in prime commercial areas of Hong Kong[29]. - The skincare retail segment faced challenges but implemented multi-faceted strategies to optimize product mix and enhance customer experience[30]. - Customer satisfaction continued to improve, with a growing customer base reflecting the company's commitment to service quality and customer experience[30]. Governance and Compliance - The company has adopted the corporate governance code and has complied with all applicable provisions as of March 31, 2025, except for specific deviations noted[59]. - The board believes that the current structure, with the same individual serving as both Chairperson and CEO, is in the best interest of the company, thus accepting the deviation from the corporate governance code[60]. - The audit committee, consisting of three independent non-executive directors, has reviewed the consolidated financial statements for the year ending March 31, 2025[63]. - The auditors confirmed that the financial figures in the preliminary announcement are consistent with the draft consolidated financial statements for the year ending March 31, 2025[64]. Other Financial Information - The provision for restoration costs increased to HKD 11,056,000 in 2025 from HKD 8,800,000 in 2024, representing a rise of 25.5%[6]. - Deferred tax liabilities decreased to HKD 2,754,000 in 2025 from HKD 4,395,000 in 2024, a reduction of 37.3%[6]. - The company had outstanding interest-bearing bank borrowings of approximately HKD 5.9 million as of March 31, 2025, down from HKD 12.5 million in FY2024[51]. - The company has no supplier financing arrangements, thus recent accounting standard amendments do not impact its financial statements[12]. - No significant events occurred after the reporting period[62].
卓珈控股(01827) - 2025 - 年度业绩